mutLBSgeneDB

mutLBSgeneDB
mutated Ligand Binding Site gene DataBase

Home

Download

 Statistics

Help

About Us

Bioinformatics and Systems Medicine Laboratory Bioinformatics and Systems Medicine Laboratory

Gene Summary

Ligand Binding Site Mutation Information

Protein Structure Related Information

Gene Expression and Gene-Gene Network

Phenotype Information

Pharmacological Information

Conservation Information for LBS

Gene summary for AGXT
Gene summary
Basic gene Info.Gene symbolAGXT
Gene namealanine-glyoxylate aminotransferase
SynonymsAGT|AGT1|AGXT1|PH1|SPAT|SPT|TLH6
CytomapUCSC genome browser: 2q37.3
Type of geneprotein-coding
RefGenesNM_000030.2,
DescriptionL-alanine: glyoxylate aminotransferase 1alanine--glyoxylate aminotransferasehepatic peroxisomal alanine:glyoxylate aminotransferaseserine--pyruvate aminotransferaseserine-pyruvate aminotransferaseserine:pyruvate aminotransferase
Modification date20141222
dbXrefs MIM : 604285
HGNC : HGNC
Ensembl : ENSG00000172482
HPRD : 05048
Vega : OTTHUMG00000133354
ProteinUniProt: P21549
go to UniProt's Cross Reference DB Table
ExpressionCleanEX: HS_AGXT
BioGPS: 189
PathwayNCI Pathway Interaction Database: AGXT
KEGG: AGXT
REACTOME: AGXT
Pathway Commons: AGXT
ContextiHOP: AGXT
ligand binding site mutation search in PubMed: AGXT
UCL Cancer Institute: AGXT
Assigned class in mutLBSgeneDBC: This gene just belongs to mutLBSgenes.

Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez
GO IDGO TermPubMed ID
GO:0009436glyoxylate catabolic process22198249
GO:0019265glycine biosynthetic process, by transamination of glyoxylate22198249
GO:0019448L-cysteine catabolic process18492492
GO:0042853L-alanine catabolic process17696873


Top
Ligand binding site mutations for AGXT

Cancer type specific mutLBS sorted by frequency
LBSAAchange of nsSNVCancer type# samples
Q208Q208HLUSC1
G29P30LSKCM1
Y260M259ISKCM1
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma.


Top
Protein structure related information for AGXT
Relative protein structure stability change (ΔΔE) using Mupro 1.1
Mupro score denotes assessment of the effect of mutations on thermodynamic stability.
  (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability)
: nsSNV at non-LBS: nsSNV at LBS

nsSNVs sorted by the relative stability change of protein structure by each mutation
Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene.
LBSAAchange of nsSNVRelative stability change
Y260M259I-1.1200128
G29P30L-0.4888661
Q208Q208H-0.25480153
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132)

Structure image for AGXT from PDB

Top
Differential gene expression and gene-gene network for AGXT
Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types

Differential co-expressed gene network based on protein-protein interaction data (CePIN)
* Left PPI network was created from samples with mutations in the LBS of AGXT and the right PPI network was created from samples without mutations in the LBS of AGXT. Only genes with p-value < 0.05 are shown.
Red circle: input gene. Orange circle: LBSgene. Blue circle: other gene.


Top

Top
Phenotype information for AGXT
Gene level disease information (DisGeNet)
Disease IDDisease name# PubMedAssociation type
umls:C0268164Primary hyperoxaluria type 169Biomarker, GeneticVariation

Mutation level pathogenic information (ClinVar annotation)
Allele IDAA changeClinical significanceOriginPhenotype IDs

Top
Pharmacological information for AGXT
Gene expression profile of anticancer drug treated cell-lines (CCLE)
Heatmap showing the correlation between gene expression and drug response across all the cell-lines. We chose the top 20 among 138 drugs.We used Pearson's correlation coefficient.

Gene-centered drug-gene interaction network
Drug information targeting mutLBSgene (Approved drugs only)
Drug statusDrugBank IDNameTypeDrug structure
NutraceuticalDB00114Pyridoxal PhosphateSmall molecule
Approved|nutraceuticalDB00133L-SerineSmall molecule
Approved|nutraceutical|vet_approvedDB00145GlycineSmall molecule
Approved|nutraceuticalDB00160L-AlanineSmall molecule
ExperimentalDB02079Aminooxyacetic acidSmall molecule
ExperimentalDB04083N'-Pyridoxyl-Lysine-5'-MonophosphateSmall molecule
ExperimentalDB080604-(2-AMINOPHENYL)-4-OXOBUTANOIC ACIDSmall molecule

Gene-centered ligand-gene interaction network

Ligands binding to mutated ligand binding site of AGXT go to BioLip
Ligand IDLigand short nameLigand long namePDB IDPDB namemutLBS
AOA(AMINOOXY)ACETIC ACID1h0cAG29
AOA(AMINOOXY)ACETIC ACID1j04AG29
PLPPYRIDOXAL 5'-PHOSPHATE1h0cAQ208
PLPPYRIDOXAL 5'-PHOSPHATE2yobAQ208
PLPPYRIDOXAL 5'-PHOSPHATE2yobBQ208
PLPPYRIDOXAL 5'-PHOSPHATE4cbrAQ208
PLPPYRIDOXAL 5'-PHOSPHATE4cbsAQ208
PLPPYRIDOXAL 5'-PHOSPHATE2yobAY260
PLPPYRIDOXAL 5'-PHOSPHATE2yobBY260


Top
Conservation information for LBS of AGXT
Multiple alignments for P21549 in multiple species
LBSAA sequence# speciesSpecies
A186LVDSVASLGGV2Mus musculus, Rattus norvegicus
A186LVDSVASLGGT1Homo sapiens
A186VVDAVCSIGCE1Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
A186LVDGVSSICAL1Arabidopsis thaliana
D183CLLLVDSVASL3Homo sapiens, Mus musculus, Rattus norvegicus
D183TFFVVDAVCSI1Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
D183ALLLVDGVSSI1Arabidopsis thaliana
G156LFLTHGESSTG2Homo sapiens, Rattus norvegicus
G156VTVTHVDTSTA1Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
G156ICIVHNETATG1Arabidopsis thaliana
G156LFLVHGESSTG1Mus musculus
G29LLLGPGPSNLA2Mus musculus, Rattus norvegicus
G29LLLGPGPSNLP1Homo sapiens
G29----PGPIILS1Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
G29----PGPVNIP1Arabidopsis thaliana
G82VVSGSGHCAME2Mus musculus, Rattus norvegicus
G82VISGSGHCALE1Homo sapiens
G82VLAGSGTLGWD1Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
G82LFPTTGTGAWE1Arabidopsis thaliana
H83VSGSGHCAMET2Mus musculus, Rattus norvegicus
H83ISGSGHCALEA1Homo sapiens
H83LAGSGTLGWDI1Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
H83FPTTGTGAWES1Arabidopsis thaliana
K209YSGSQKALNAP1Homo sapiens
K209LTASQKAIGAP1Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
K209LTGSQKALSLP1Arabidopsis thaliana
K209YSSSQKVLNAP1Mus musculus
K209YSGSQKVLNAP1Rattus norvegicus
L351EIMGGLGPSTG1Homo sapiens
L351VIAGGIHKDIG1Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
L351SLGLGLNKVAG1Arabidopsis thaliana
L351EISGGLGPTEE1Mus musculus
L351EISGGLGPSED1Rattus norvegicus
M348FDIEIMGGLGP1Homo sapiens
M348HGVVIAGGIHK1Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
M348YNLSLGLGLNK1Arabidopsis thaliana
M348FSIEISGGLGP1Mus musculus
M348FNIEISGGLGP1Rattus norvegicus
P28RLLLGPGPSNL2Mus musculus, Rattus norvegicus
P28QLLLGPGPSNL1Homo sapiens
P28-----PGPIIL1Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
P28-----PGPVNI1Arabidopsis thaliana
Q208LYSGSQKALNA1Homo sapiens
Q208ALTASQKAIGA1Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
Q208ALTGSQKALSL1Arabidopsis thaliana
Q208MYSSSQKVLNA1Mus musculus
Q208LYSGSQKVLNA1Rattus norvegicus
R360G-KVLRIGLLG1Homo sapiens
R360GPKYIRIGHMG1Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
R360G-KVFRIGHLG1Arabidopsis thaliana
R360E-RVLRIGLLG1Mus musculus
R360D-KVLRIGLLG1Rattus norvegicus
S158LTHGESSTGVL2Homo sapiens, Rattus norvegicus
S158VTHVDTSTAVL1Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
S158IVHNETATGVT1Arabidopsis thaliana
S158LVHGESSTGVV1Mus musculus
S81LVVSGSGHCAM2Mus musculus, Rattus norvegicus
S81LVISGSGHCAL1Homo sapiens
S81FVLAGSGTLGW1Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
S81FLFPTTGTGAW1Arabidopsis thaliana
T263RMYHHTIPVIS1Homo sapiens
T263GAYFATPPVQL1Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
T263-YWPYTPSIQL1Arabidopsis thaliana
T263RVIHHTTPVTS1Mus musculus
T263RVIHHTLPVIS1Rattus norvegicus
V185LLVDSVASLGG3Homo sapiens, Mus musculus, Rattus norvegicus
V185FVVDAVCSIGC1Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
V185LLVDGVSSICA1Arabidopsis thaliana
W108GANGIWGQRAV1Homo sapiens
W108VSTGTFSDRFA1Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
W108FLIGQFSLLWI1Arabidopsis thaliana
W108GTNGIWGMRAA1Mus musculus
W108GTNGIWGIRAA1Rattus norvegicus
Y260DQPRMYHHTIP1Homo sapiens
Y260AGKGAYFATPP1Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
Y260LGT-YWPYTPS1Arabidopsis thaliana
Y260GETRVIHHTTP1Mus musculus
Y260GKTRVIHHTLP1Rattus norvegicus


Copyright © 2016-Present - The University of Texas Health Science Center at Houston
Site Policies | State of Texas